Skip to main content
MyCapitol LogoMyCapitol

S 476 · 118th Congress

Maintaining Investments in New Innovation Act

<p><b>Maintaining Investments in New Innovation Act</b></p> <p>This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare &amp; Medicaid Se…

Sponsor
Menendez, Robert (D-NJ)
Introduced
2023-02-16
Policy area
Health
Latest action
Read twice and referred to the Committee on Finance.

Digging through Congress... 🔍